Latest News

Tuesday, August 15, 2017 | Neuromuscular & Immune Disorders, Research and Publications

Gut Bacteria May Play Preventive Role in MS

New findings support the increasingly prominent hypothesis that gut bacteria play a role in autoimmune diseases such as multiple sclerosis (MS). Specifically, a study published in Cell Reports (Aug;20…

Read the full story

Thursday, August 10, 2017 | Healthcare Trends, Research and Publications, Stroke & Cerebrovascular

Stroke Rates Decreasing Among Men, Steady in Women

Although stroke incidence rates are dropping overall, new findings suggest that those decreases are only seen in men. In a new study published in Neurology (published online August 9), investigators t…

Read the full story

Tuesday, August 08, 2017 | FDA Approval/Clearance, Neuromuscular & Immune Disorders, Personnel/Company News

Recently Approved ALS Treatment Radicava Now Available

Radicava (edaravone, Mitsubishi Tanabe Pharma America), an intravenous therapy indicated for all adult patients diagnosed with amyotrophic lateral sclerosis (ALS), is now available for treatment in th…

Read the full story

Tuesday, August 01, 2017 | FDA Approval/Clearance, Pain & Headache

Non-Invasive Neuromodulation Device for Chronic Intractable Pain Cleared by FDA

The FDA has cleared the Stimpod NMS460 (Xavant Technology), a non-invasive neuromodulation device for the symptomatic relief and management of chronic intractable pain. When applied to the affected ar…

Read the full story

Tuesday, July 25, 2017 | Research and Publications, Visual & Sensory Disturbances

Largest CTE Study in Football Players to Date Finds Pathological Diagnosis in 110 out of 111 NFL Players

The already compelling evidence tying football to chronic traumatic encephalopathy (CTE) is now even stronger, with the publication of findings from the largest study yet to evaluate the brains of dec…

Read the full story

Friday, July 21, 2017 | FDA Approval/Clearance, Imaging & Testing

FDA Clears First MRI System for Neonatal Brain Imaging

The FDA cleared the Embrace Neonatal MRI System, the first of its of its king specifically for neonatal brain and head imaging in neonatal intensive care units (NICU). The Embrace Neonatal MRI System …

Read the full story

Wednesday, July 19, 2017 | Product Launches and Updates

CSL Behring: FDA Accepts sBLA for Hizentra® for Chronic Inflammatory Demyelinating Polyneuropathy

The FDA has accepted for review CSL Behring’s supplemental Biologics License Application (BLA) for Hizentra®([Immune globulin subcutaneous [Human] 20% liquid) for the treatment for…

Read the full story

Monday, July 17, 2017 | Dementia & Cognitive Disorders

AAIC 2017: Electronic Self-Administered Test Performs Similarly to Pen-and-Paper Version in Detecting MCI and Early Dementias

Findings presented at the Alzheimer’s Association International Conference in London indicate that the self-administered eSAGE (BrainTest Inc.) test performs similar to its validated pen-an…

Read the full story

Monday, July 17, 2017 | Dementia & Cognitive Disorders, Research and Publications

AAIC 2017: Healthy Diets Tied to Decreased Likelihood of Cognitive Impairment In Older Individuals

The benefits of a healthy diet may extend to cognitive health, according to findings presented at the Alzheimer’s Association International Conference in London. Among nearly 6,000 older adults …

Read the full story

Thursday, July 13, 2017 | Movement Disorders

Sage Bionetworks Launches DREAM Challenge to Identify Best Uses for Remote Sensing Devices

Sage Bionetworks has launched the Parkinson’s Disease Digital Biomarker DREAM Challenge, the first in a series of open, crowd-sourced analytical projects to help researchers identify ways to use…

Read the full story

Wednesday, July 12, 2017 | Movement Disorders, Research and Publications

Visual System Changes May Represent an Early Signal of Parkinson’s Disease

Changes in the intracranial visual system may be a signal of Parkinson’s disease (PD), according to new findings published in Radiology. Using MRI, researchers evaluated 21 patients with newly d…

Read the full story

Thursday, July 06, 2017 | Dementia & Cognitive Disorders, Research and Publications, Sleep

Sleep Disturbances Linked to Alzheimer’s Disease

Poor sleep may be a sign that otherwise healthy individuals may have an increased risk of developing Alzheimer’s disease later in life over those who do not have sleep problems, according to a s…

Read the full story

Friday, June 30, 2017 | Epilepsy & Seizure Disorders, Product Launches and Updates

VNS Therapy Approved in Children Ages Four Years and Older with Partial Onset Refractory Seizures

The FDA has approved the VNS Therapy (LivaNova) in patients as young as four years of age with partial onset refractory seizures. Originally approved for patients ages 12 years and older, VNS The…

Read the full story

Tuesday, June 27, 2017 | Dementia & Cognitive Disorders

Phase 3 Results Suggest Promise of Investigational Alzheimer’s Agent in Mild Disease

New Phase 3 findings published in the Journal of the Prevention of Alzheimer’s Disease show that Alzheon’s investigational agent tramiprosate (ALZ-801) may offer cognitive and functional b…

Read the full story

Tuesday, June 27, 2017 | Epilepsy & Seizure Disorders, Phase 3/4 Trials

Low-Dose Fenfluramine Granted Orphan Status for LGS

The FDA has granted orphan drug designation to ZX008 (Zogenix), an investigational treatment for Lennox Gastaut Syndrome (LGS). Zogenix will initiate a Phase 3 clinical trial in LGS in second half of …

Read the full story
Load More